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 ABSTRACT 
 Objectives To examine the validity and reliability of the Menopause-specifi c Quality of Life (MENQOL) 
questionnaire in a sample of women with diabetes in Malaysia, with the secondary aim of determining whether 
MENQOL domain scores were associated with depression and diabetes. 
 Methods A total of 337 postmenopausal women (241 with diabetes, 96 controls) were evaluated. Construct 
validity was evaluated using principal components analysis (PCA) and comparing scale items against the 
mental component score of the Short Form-12 (SF-12 MCS), and against the Center for Epidemiologic Stud-
ies Depression Scale 10 (CES-D 10). Consistency assessment was conducted using Cronbach ’ s  α . 
 Results The internal consistencies for the physical (PHS), psychosocial (PS), sexual (VSS) and vasomotor 
domains were 0.86, 0.79, 0.79 and 0.70, and 0.90 for the full scale of MENQOL. PCA revealed a four-
factorial model. Diabetes and non-diabetes subjects experienced their fi rst period (13.25 vs. 13.10 years, 
 p    0.680) and achieved menopause around the same age (49.35 vs. 48.87 years,  p    0.426). We found sig-
nifi cant variations in the MENQOL ’ s PHS and PS domain scores that could be explained by SF-12 PCS (25%) 
and SF-12 MCS (20%) sub-scales. The validity of the MENQOL domains was demonstrated through sig-
nifi cant associations with the equivalent SF-12 MCS and PCS subscales. The PS domain of the MENQOL 
also predicted the likelihood of symptoms of depression (1.42, 95% confi dence interval 1.01 – 2.02). 
 Conclusions This study confi rms the validity and internal consistency of the MENQOL questionnaire for 
measuring quality of life in postmenopausal women with diabetes, suggesting that the instrument can be used 
to screen people for menopausal symptoms. 
 INTRODUCTION 
 Being one of the leading causes of death globally, type 2 
diabetes mellitus prevails across both genders; however, its 
prevalence and complications increase among women aged 
65 years and older 1,2 . In Malaysia, up to 1.2 million individu-
als are experiencing diabetes, out of which more than half are 
undiagnosed 3 . Moreover, with an alarming and colossal 
increase, within a decade, the prevalence of diabetes has 
drastically risen from 8.3% in 1996 to 14.9% in 2006 3,4 . In 
2010, of the Malaysians diagnosed with diabetes, 11.6% were 
women and this fi gure is speculated to reach a height of 
13.8% in the year 2030 5 . Furthermore, a higher prevalence 
of type 2 diabetes has been reported among women with a 
history of menstrual irregularity 6 , particularly in those with 
long and highly irregular menstrual cycles 7 . 
 Diabetes has detrimental effects on health outcomes 8 and 
its personal and social predicaments are well studied 9,10 . For 
instance, studies have shown signifi cant negative associations 
between quality of life and progression of disease in different 
populations, for example, elderly women 9,10 . Clearly, it is 
important to be able to examine quality of life accurately 
in postmenopausal women with diabetes. In general, women 
in the transition phase, i.e. perimenopausal phase or those 
who have already achieved menopause, experience more 
menopausal symptoms compared to premenopausal women 
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in terms of frequency and severity. Specifi cally, women in the 
perimenopausal and postmenopausal years experience signifi -
cantly more vasomotor, sexual and psychosocial symptoms 
compared to women in the premenopausal years 11 – 13 . 
 Menopausal symptoms as measured by the Menopause-
specifi c Quality of Life (MENQOL) questionnaire in post-
menopausal women have a negative impact on health-related 
quality of life 14 . The 29-item MENQOL questionnaire 15 has 
been widely used in different populations 11,16 – 20 . This tool 
captures the health-related quality of life in four domains, i.e. 
vasomotor, physical, psychosocial, and sexual functioning 15 . 
Additionally, the psychometric properties, detailed factorial 
analysis and validation of the MENQOL instrument in older 
women (   60 years) have been reported using a Western 
non-diabetes population 21,22 . 
 Interestingly, there is a commonality among some of the 
postmenopausal symptoms and those reported by individuals 
diagnosed with diabetes. The MENQOL questionnaire con-
tains some items that could be confounded with the symptoms 
of poorly controlled diabetes. These symptoms are, and not 
limited to, depression, anxiety, and sleep problems 23 – 26 . Ques-
tions relating to symptoms such as frequent urination and lack 
of energy (which may also be related to symptoms of diabetes) 
are also included in the MENQOL scale 23 – 26 . 
 It seems that there is dearth of data on the validity of 
measuring these symptoms in a menopausal population with 
diabetes. Moreover, variations in reported symptoms between 
Asian and Caucasian women have been well established, 
where Asian women suffer less vasomotor and psychological 
symptoms than Western women 11,18 – 20 . However, little is 
known about symptoms experienced by menopausal women 
with diabetes, particularly those living in the Asia-Pacifi c 
region. 
 Although the MENQOL questionnaire has been adminis-
tered in women with type 2 diabetes mellitus in Nigeria 27 , and 
those at risk of metabolic syndrome in Ecuador 17 , this is the 
fi rst study to validate the MENQOL questionnaire using post-
menopausal women, with and without diabetes in Malaysia. 
We are interested to determine whether MENQOL could be 
used to examine quality of life in postmenopausal women 
with diabetes. We explored both the validity of the MENQOL 
domains and their association with symptoms of depression 
in a sample of women with diabetes in Malaysia. 
 MATERIALS AND METHODS 
 Study design and population 
 In this case – control study, we recruited women aged 35 – 75 
years with type 2 diabetes mellitus (case) and matched them 
with women without type 2 diabetes (control) in the same age 
range. Each case was a woman with a known diagnosis of 
diabetes; and subsequently the control was a woman with no 
known diagnosis of diabetes. The diagnosis of diabetes or 
absence of diabetes was confi rmed by medical records. Meno-
pausal status was identifi ed as premenopausal (no irregular 
periods in the previous 12 months), perimenopausal (irregular 
periods for less than 12 months), or postmenopausal (cessa-
tion of menses for 12 months or longer). Since MENQOL is 
validated only in a postmenopausal population, MENQOL 
assessment was restricted to postmenopausal women only. 
 Women with diabetes were recruited from outpatient clinics 
at PutraJaya Hospital in PutraJaya, Tuanku Jaa ’ far Hospital 
and Seremban Health Clinic, both in Negeri Sembilan, one of 
the states of Peninsular Malaysia. The control subjects were 
healthy friends or unrelated family members with no blood 
relationship, for example, inlaws of people with diabetes. 
 The study was conducted according to the principles 
expressed in the Declaration of Helsinki and was approved 
by the School of Pharmacy Ethics Committee at the Interna-
tional Medical University Research and Ethics Committee 
(Project ID No: B01/09-Res (04) 2012). The study was also 
registered with the National Medical Research Registry 
(NMRR), Ministry of Health Malaysia. 
 Procedures and measures 
 Data on diabetes were collected through a self-administered 
questionnaire, where women were asked  ‘ Have you EVER 
been told by a doctor that you have diabetes (high blood 
sugars)? ‘ , with response options  ‘ yes ’ or  ‘ no ’ . Subjects were 
categorized as having diabetes if they had been told by a phy-
sician that they had diabetes. This information was further 
confi rmed by patients ’ medication records, fasting plasma glu-
cose    7.0 mmol/l, and random plasma glucose greater than 
or equal to 11.1 mmol/l. Subjects were not recruited if data 
on their fasting glucose levels were missing. 
 Women participating in this study were assessed for depres-
sive symptoms using the Center for Epidemiologic Studies 
Depression Scale (CES-D), 10-item and for quality of life using 
the Outcomes Survey Short Form (SF), 12-item scales. 
 Construct validity of MENQOL domains 
 We assessed the validity of the MENQOL domains against 
the presence or absence of diabetes. We also examined the 
differences in the symptoms commonly reported in both dia-
betes and postmenopause. We determined the degree to 
which presence or absence of diabetes was related to quality 
of life on the MENQOL domains, as individuals with diabe-
tes are linked to signifi cant decrements in dimensions of qual-
ity of life 8,28 . 
 The MENQOL is a validated instrument used to measure 
quality of life and is able to capture not only the existence of 
frequent menopausal symptoms, but also the extent to which 
the symptom(s) is/are bothersome 15,21 . For analyses, we scored 
the items from 1 to 8 in the following manner: (1) The subject 
responded  ‘ No ’ , she did not experience the problem; (2) the 
subject experienced the problem and rated it as  ‘ 0 ’ on the 
bothered scale; (3) the subject experienced the problem and 
rated it as  ‘ 1 ’ on the bothered scale; (4) rated as  ‘ 2 ’ ; (5) rated 
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as  ‘ 3 ’ ; (6) rated as  ‘ 4 ’ ; (7) rated as  ‘ 5 ’ ; (8) rated as  ‘ 6 ’ . Each 
domain score ranges from 1 to 8;  ‘ 1 ’ implies good health and 
 ‘ 8 ’ implies poor health 15,21 . 
 We re-validated the MENQOL psychosocial and physical 
domains against the Short Form (SF-12) instrument, a vali-
dated and generic measure of health status that assesses both 
physical and mental quality of life 29 – 31 . SF-12 is a multipur-
pose survey instrument comprising 12 questions, developed 
as a legitimate alternative to the SF-36. The two summary 
scales, the Mental (MCS) and the Physical Component Sum-
mary (PCS), provide an insight into mental and physical 
health 32 . As described elsewhere 32,33 , the MCS score assessing 
impact of health on mental health function was calculated. 
The MCS includes subscales that measure vitality (VT), social 
function (SF), mental health (MH), and role function-
emotional (i.e. the extent to which one ’ s emotional problems 
limit one ’ s role function, RE). The PCS includes subscales that 
measure physical functioning (PF), role physical (RP), bodily 
pain (BP), and general heath (GH). The scores were calculated 
using the scores of the questions that range from 0 to 100;  ‘ 0 ’ 
implies poor health and  ‘ 100 ’ implies good health. Unlike 
the MENQOL domains, higher SF-12 component scores 
represent better quality of life. We assessed the validity of the 
MENQOL ’ s sexual domain indirectly against marital status. 
The rationale behind this indirect validation is described 
elsewhere 22,34 . 
 We also examined the degree to which depression symp-
toms were associated with quality of life on the MENQOL 
psychosocial domain. CES-D 10, a screening tool for depres-
sive symptoms 35 , has been used in people with diabetes 36 and 
was now used to assess depression symptoms. The shorter 
form contains ten depression items and is easier and quicker 
to administer in clinical and non-clinical settings. It has been 
shown to have reliability and validity comparable to the stan-
dard 20-item CES-D instrument and is considered a good 
instrument for screening depression in patients with diabe-
tes 36 . The CES-D 10 uses a 0 – 3 response scale, with total 
symptom severity scores ranging from 0 (no depression) to 30 
(severe depression) 37 . Participants in this study were catego-
rized as depressed if they scored 11 or more on the CES-D 
10 scale. Higher scores on the MENQOL indicate a poorer 
quality of life. Higher scores on the CES-D indicate greater 
depression symptoms. 
 Statistical analysis 
 The data were analyzed using the Statistical Package for Social 
Sciences (SPSS)  ®  version 20 and STATA IC  ®  version 12, with 
a signifi cance level of    0.05. Descriptive statistics were used 
to calculate percentage frequencies, means and standard devi-
ations. Since MENQOL had not been previously validated in 
a sample of women with diabetes, we conducted a principal 
component analysis (PCA) to examine the underlying compo-
nents or domains of MENQOL. In order to achieve a favor-
able ratio (   10 : 1) of respondents over instrument items, a 
minimum of 200 participants was required to conduct factor 
analysis. Next we performed the Kaiser – Meyer – Olkin test 
(KMO) to measure sampling adequacy of    0.7. An eigen-
value    1 was used for retaining factors in PCA. However, 
there are chances of potential biases that can be introduced 
by the use of a cut-off value    1. Therefore, we inspected the 
Scree plot, as a superior factor selection method to determine 
the appropriate number of factors to retain for rotation. 
Bartlett ’ s test of sphericity was used to measure signifi cant 
correlations between variables. The corrected item-total score 
correlations were also examined. Reliability of MENQOL 
items and domains were assessed using Cronbach ’ s  α and 
intra-class correlation coeffi cients, where an  α of 0.70 – 0.90 
was considered good. 
 The independent  t -test was applied to obtain the mean 
(95% confi dence interval) and statistical differences between 
mean MENQOL symptoms and domain scores (continuous 
variable) and diabetes (categorized as  ‘ yes ’ or  ‘ no ’ ). To vali-
date the MENQOL physical and psychosocial domains against 
the SF-12 physical and mental component summary scores, 
linear regression was used. Age was included as a covariate 
(continuous variable) in the regression analyses to control for 
potential confounding effects. Education and diabetes were 
included as covariates to control for potential effects on qual-
ity of life 8 – 10,38 . Age, education and diabetes were included as 
covariates in all linear and logistic regression analysis used in 
this study. Linear regression was also used to validate the 
sexual domain with marital status. Finally, logistic regression 
analysis determined the degree to which depression symptoms 
and diabetes were associated with quality of life on the 
MENQOL domains. 
 RESULTS 
 Sociodemographic characteristics 
 Out of total of 640 participants, half ( n    320) were identifi ed 
as  ‘ case ’ while the remaining half ( n    320) were identifi ed as 
 ‘ control ’ . The overall mean age was 57.43 years, standard 
deviation    6.28 years. The mean age at diabetes diagnosis 
was 47.75    9.81 years, with all receiving oral hypoglycemic 
drugs and/or insulin. Diabetes subjects were older than con-
trol subjects (60.22 vs. 54.64 years). The majority of the 
women were Malay and had attained secondary education. 
Women with diabetes were mostly homemakers with no paid 
jobs and no monthly income, while control subjects were 
mostly government or non-government employees, working 
41 h or more per week with a monthly income of less than 
RM 3500. 
 Both  ‘ case ’ and  ‘ control ’ subjects experienced their fi rst 
period around the same age (mean age 13.25 vs. 13.10 years, 
 p    0.680). Similarly, they achieved menopause around the 
same age (mean age 49.35 vs. 48.87 years,  p    0.426). Regard-
ing menopausal status, more diabetes subjects had attained 
menopause compared to control subjects (37.7% vs. 15.0%, 
 p    0.001). However, more control subjects had perimeno-
pausal status compared to women with diabetes (11.2% vs. 
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2.5%, p    0.001). Diabetes subjects had a higher number of 
pregnancies compared to control subjects (mean 4.15 vs. 3.64, 
 p    0.001) (Table 1). 
 Score distributions 
 There were small  ‘ fl oor ’ effects for all domains and the total 
score. However, there was a modest amount of  ‘ ceiling ’ effect, 
particularly in vasomotor and sexual domains, as shown in 
Table 2. 
 PCA and reliability 
 The 29 items of MENQOL were entered into an iterated PCA 
with Kaiser normalization. The KMO test of sampling ade-
quacy was applied prior to factor extraction, which resulted 
in an overall index of 0.95, suggesting that the sample was 
adequate for factor analysis. Inspection of the corresponding 
Scree plot and identifi cation of an  ‘ elbow ’ point, after which 
the inclusion of additional factors does not result in substan-
tial gains in variance explained, yielded the existence of 
four factors, with eigenvalues more than one. The non-rotated 
factor produced the most explanation of the data and excel-
lent loadings. 
 Reliability coeffi cients were constructed for each domain of 
the MENQOL. Cronbach ’ s  α statistics were acceptable for 
each of the domains (Table 2). The values for the physical, 
psychosocial, sexual and vasomotor domains were 0.86, 0.79, 
0.79 and 0.70, respectively and 0.90 for the full scale of 
MENQOL. The Cronbach’s  α values of MENQOL domains 
were almost comparable for diabetes and control subjects. 
 Construct validity 
 Since MENQOL is only validated in a postmenopausal popu-
lation, MENQOL assessment was restricted to postmeno-
pausal women only (241 cases, 96 controls). Table 3 displays 
the results of the linear regression analysis of the validation 
instruments including covariates on MENQOL psychosocial 
and physical domains. Our results indicated that better qual-
ity of life on the SF-12 physical and mental component scores 
was signifi cantly related to better quality of life on the physi-
cal (correlation coeffi cient    0.497) and psychosocial (correla-
tion coeffi cient    0.436) domains of the MENQOL. 
 When the SF-12 mental component score increased by one 
unit, the MENQOL psychosocial domain score decreased by 
0.029 units. Performance on the SF-12 mental component 
accounted for 20% of the variance in the MENQOL psycho-
social domain scores. When the SF-12 physical component 
score increased by one unit, the MENQOL physical domain 
score decreased by 0.026 units. Performance on the SF-12 
physical component accounted for 25% of the variance in the 
MENQOL physical domain scores. 
 When age increased by 1 year, the scores for MENQOL 
vasomotor domain ( p    0.699), psychosocial domain 
( p    0.444), physical domain ( p    0.442), and sexual domain 
( p    0.394) decreased by 0.005, 0.008, 0.007, and 0.010 
units, respectively. The association between SF-12 summary 
scales and MENQOL domains remained signifi cant after 
adjusting for age, education, and diabetes. The logistic regres-
sion analysis showed that MENQOL vasomotor, physical, 
and sexual domains actually decreased by small amounts, 
0.099 (95% CI -0.463 – 0.264), 0.185 (95% CI -0.479 – 0.109), 
and 0.048 (95% CI -0.388 – 0.293), for women with diabetes. 
The effects on the psychosocial domain (increased by 0.310) 
 Table 1 Descriptive statistics of issues related to reproduction, by 
case and control ( n    640). Data are given as mean   standard 
deviation or  n (%) 
 Diabetes  Control  p Value 
Age at time of study 
(years)
60.22  

  7.07 54.64  

  5.49 0.001
Age at last pregnancy 
(years)
27.53  

  4.32 29.41  

  3.28 0.001
Age at menopause (years) 49.35  

  5.19 48.87  

  4.16 0.426
Age when periods started 
(years)
13.25  

  3.27 13.10  

  1.37 0.680
Number of pregnancies 4.15  

  1.93 3.64  

  1.94 0.001
 Menopausal status 
Premenopausal 63 (9.8%) 152 (23.7%) 0.001
Perimenopausal 16 (2.5%) 72 (11.2%) 0.001
Postmenopausal 241 (37.7%) 96 (15.0%) 0.001
 Table 2 Values of Cronbach ’ s  α and scores of participants with diabetes, by domains of the Menopause-
specifi c Quality of Life (MENQOL) questionnaire ( n    241) 
 MENQOL 
domain  Cronbach ’ s  a 
 Mean  

 
standard 
deviation  Median 
 ’Floor ’ effects 
(worst health score) 
n (%)
 ’Ceiling ’ effects 
(best health score) 
n (%)
Vasomotor 0.70 1.98  

  1.25 1.33 0 (0.0) 63 (26.14)
Psychosocial 0.79 2.44  

  1.38 2.00 1 (0.41) 20 (8.30)
Physical 0.86 2.85  

  1.29 2.69 0 (0.0) 6 (2.49)
Vaginal sexual 0.79 1.53  

  1.25 1.00 0 (0.0) 75 (31.12)
Total (full scale) 0.90 2.53  

  1.09 2.38 0 (0.0) 0 (0.0)
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are probably in the same direction to that expected, but for 
which the confi dence intervals span negative and positive 
values. 
 Table 4 shows the results of the logistic regression analysis 
examining the association between depression symptoms and 
each of the four MENQOL domains. The odds that a woman 
was depressed on the CES-D scale increased 1.42 times when 
the MENQOL score on the psychosocial domain increased by 
one unit (95% confi dence interval (CI) 1.01 – 2.02), and the odds 
ratio increased 1.27 times when the MENQOL score on the 
physical domain increased by one unit (95% CI 0.82 – 1.97). 
 The linear regression results also indicated that being mar-
ried was associated with better quality of life on the MEN-
QOL sexual domain; the mean sexual domain scores of mar-
ried women were on average 0.482 units lower compared to 
those who were not married. Marital status accounted for 7% 
of variance in the MENQOL sexual domain scores. Women 
with secondary education or higher had greater quality of life 
complaints on the sexual domain compared to women with 
primary education or lower (Table 3). 
 The results of the logistic regression analysis examining 
the association between diabetes and quality of life, as deter-
mined by each of the four MENQOL domains, can be found 
in Table 5. The odds of presence or absence of diabetes increased 
1.13 times when the MENQOL score on the psychosocial 
domain increased by one unit (95% CI 0.92 – 1.39), and the 
odds ratio increased 0.99 times when the MENQOL score on 
the physical domain increased by one unit (95% CI 0.80 – 1.22). 
However, none of them were statistically signifi cant. 
 For symptoms associated with both diabetes and post-
menopausal stage, diabetes subjects had signifi cantly higher 
mean scores compared to control subjects (Table 6). Of the 
three vasomotor symptoms, i.e. night sweats, hot fl ushes 
and sweating, only hot fl ushes were signifi cantly higher in 
control subjects. 
 DISCUSSION 
 The MENQOL questionnaire appears to be reliable and valid 
instrument based on good internal consistency and signifi cant 
correlations with validated instruments. As a fi rst study to 
explore the validity of a MENQOL measure in a sample of 
postmenopausal women with diabetes who completed the 
MENQOL, a quality-of-life measure developed and validated 
for both younger and older postmenopausal women, this 
study provides support for the validity of the MENQOL 
domains in women with diabetes. The MENQOL domains 
 Table 3 Results of linear regression analyses with the Menopause-specifi c Quality of Life (MENQOL) domains as 
the dependent variables and the SF-12 component scores, marital status, age, education, and diabetes as independent 
variables ( n    337) 
 Parameter 
coeffi cients  p Value 
 95% confi dence 
interval  Variance R 2 
 Correlation 
coeffi cients 
 Vasomotor domain (VS) 
Age   0.005 0.699   0.028 – 0.019 1.0 Age: VS     0.052
Diabetes  *    0.099 0.591   0.463 – 0.264
Education  †  0.088 0.630   0.271 – 0.448
 Psychosocial domain (PS) 
SF-12 MCS   0.029 0.001   0.036 to   0.023 0.879 MCS: PS     0.436
Age   0.008 0.444   0.029 – 0.013 Age: PS     0.012
Diabetes 0.310 0.059   0.011 – 0.629
Education   0.048 0.764   0.366 – 0.269
 Physical domain (PHS) 
SF-12 PCS   0.026 0.001   0.031 to   0.022 0.804 PCS: PHS     0.497
Age   0.007 0.442   0.026 – 0.012 Age: PHS    0.045
Diabetes   0.185 0.217   0.479 – 0.109
Education   0.082 0.576   0.372 – 0.207
 Vaginal sexual domain (VSS) 
Marital status  ‡    0.482 0.006   0.822 to   0.142 0.937 Age: VSS     0.165
Age   0.010 0.394   0.033 – 0.129
Diabetes   0.048 0.373   0.388 – 0.293
Education 0.337 0.054   0.006 – 0.679
 PCS, physical component score; MCS, mental component score 
  *  , Diabetes refers diabetes or no diabetes (1    diabetes; 0    no diabetes);   †  , education was measured as 1    primary 
schooling or lower; 2    secondary schooling or higher;   ‡  , married    1; not presently married, i.e. divorced, single, 
widowed    0 
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were signifi cantly associated with the well validated and 
widely used CES-D and SF-36 MCS scales, supporting the 
construct validity of MENQOL for use among women with 
diabetes. Our observations also revealed that the MENQOL 
questionnaire is an easy-to-administer instrument for measur-
ing menopausal symptoms. 
 The results provide evidence supporting the reliability of the 
MENQOL questionnaire for use among diabetes subjects. Val-
ues of Cronbach’s  α for the sexual, physical, vasomotor and 
psychosocial domains were 0.79, 0.86, 0.70, and 0.79, respec-
tively. The full MENQOL scale had a high internal consistency 
of 0.90, suggesting that 29 items included in the instrument 
are reliable. Cronbach’s  α was more than 0.80 for both diabe-
tes and control subjects. These values of  α are comparable with 
those reported in a previous study 21 . An interesting fi nding of 
this study is the four-factorial model of the MENQOL, similar 
to the ones reported earlier 21 , where the items loaded fully on 
the four factors, confi rming the psychometric properties of 
MENQOL for use among women with diabetes. However, few 
items were cross-loaded on more than one domain. Consistent 
with the development of the scale, it is encouraging that items 
overwhelmingly operate in the way that they were intended. 
 The validity of the MENQOL psychosocial and physical 
domains was demonstrated through strong relationships with 
the equivalent SF-12 mental and physical component scales. 
Our results indicated that better SF-12 MCS and PCS scores 
were signifi cantly related to lower psychosocial and physical 
symptoms of the MENQOL. These results remained signifi -
cant even when the covariates of age, education, and diabetes 
were included in the regression models. Interestingly, diabetes 
was not a signifi cant covariate and did not change the associa-
tion between SF-12 component scales and MENQOL physical 
and psychosocial domains, suggesting that presence or absence 
of diabetes does not change the quality-of-life measures on 
the MENQOL instrument. 
 Three domains on the MENQOL (vasomotor, physical and 
sexual domains) did not predict the risk of depressive symp-
toms. Consistent with a previous study, the psychosocial 
domain of the MENQOL did predict the likelihood of symp-
toms of depression 22 . This particular fi nding is important 
because the psychosocial domain consists of items measuring 
the infl uence of depressive symptoms, providing validity to 
the psychosocial domain of the MENQOL. This fi nding may 
be useful in a clinical setting as responses to MENQOL may 
suggest concurrent problems of depression. 
 Our observations also revealed that diabetes subjects had 
signifi cantly higher mean scores compared to non-diabetes 
subjects for symptoms associated with both diabetes and the 
postmenopausal period. However, none of the domains on the 
MENQOL scale predicted the likelihood of diabetes. The 
study has also shown that the mean ages of occurrence of 
menopause in women with and without type 2 diabetes are 
not signifi cantly different (49.35 vs. 48.87 years). However, 
more women with diabetes had attained menopause compared 
 Table 4 Results of logistic regression analyses with depression symptoms as the dependent variables and 
the Menopause-specifi c Quality of Life (MENQOL) domains, age, education, diabetes, and marital status 
as the independent variables ( n    337) 
 Depression  *  
 Odds ratio point 
estimates  p Value 
 95% confi dence 
interval  Variance R 2 
 Vasomotor domain 1.22 0.252 0.87 – 1.70 0.018
Age 1.01 0.818 0.92 – 1.12
Diabetes 0.67 0.585 0.16 – 2.77
Education 1.26 0.768 0.27 – 5.92
Marital status 1.66 0.467 0.42 – 6.56
 Psychosocial domain 1.42 0.050 1.01 – 2.02 0.050
Age 1.01 0.780 0.92 – 1.12
Diabetes 0.59 0.466 0.15 – 2.41
Education 1.42 0.658 0.30 – 6.75
Marital status 1.73 0.438 0.44 – 6.89
 Physical domain 1.27 0.289 0.82 – 1.97 0.022
Age 1.01 0.864 0.92 – 1.12
Diabetes 0.64 0.534 0.16 – 2.62
Education 1.34 0.711 0.28 – 6.35
Marital status 1.66 0.470 0.42 – 6.62
 Vaginal sexual domain 1.23 0.246 0.87 – 1.72 0.023
Age 1.01 0.840 0.92 – 1.12
Diabetes 0.66 0.563 0.16 – 2.65
Education 1.18 0.836 0.25 – 5.64
Marital status 1.91 0.369 0.47 – 7.86
  *  , Depression was measured with CESD-10: depressed    1; not depressed    0 
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to women without diabetes (37.7% vs. 15.0%,  p    0.001). 
The age of onset of menopause in this study is comparable 
with that reported in previous studies 27,39 – 41 . It should be 
noted that the menopausal state may be a potential risk factor 
for the development of metabolic syndrome 42 which could 
subsequently lead to diabetes. 
 Overlap of symptoms 
 Women with diabetes had signifi cantly higher mean scores for 
the MENQOL symptoms or items that could be confounded 
with the symptoms of diabetes or poorly controlled diabetes 
compared to women without diabetes; we did not fi nd signifi cant 
differences for any of the MENQOL domains. This fi nding sug-
gests that MENQOL can be administered in a population with 
diabetes. The instruments used for screening depression symp-
toms also contained some items that could be confounded with 
symptoms of diabetes or poorly controlled diabetes 43 . For exam-
ple, questions relating to symptoms such as loss of appetite and 
restless sleep (which may also be related to symptoms of diabe-
tes) are included in the CES-D scale 35 . 
 Limitations 
 Although we applied systematic sampling, participants who 
frequently attended the outpatient clinics were more likely to 
 Table 5 Results of logistic regression analyses with diabetes as the dependent variable and the Menopause-
specifi c Quality of Life (MENQOL) domains, age, education, and marital status as the independent variables 
( n    337) 
 Diabetes  *  
 Odds ratio point 
estimates  p Value 
 95% confi dence 
interval  Variance R 2 
 Vasomotor domain 0.93 0.460 0.78 – 1.12 0.177
Age 1.11 0.001 1.06 – 1.17
Marital status  ‡  1.15 0.698 0.57 – 2.32
Education  †  0.16 0.001 0.10 – 0.39
 Psychosocial domain 1.13 0.249 0.92 – 1.39 0.179
Age 1.11 0.001 1.06 – 1.17
Marital status 1.17 0.666 0.58 – 2.36
Education 0.16 0.001 0.10 – 0.40
 Physical domain 0.99 0.923 0.80 – 1.22 0.175
Age 1.11 0.001 1.06 – 1.17
Marital status 1.16 0.686 0.58 – 2.33
Education 0.15 0.001 0.10 – 0.39
 Vaginal sexual domain 0.96 0.686 0.81 – 1.15 0.176
Age 1.11 0.001 1.06 – 1.17
Marital status 1.13 0.741 0.55 – 2.30
Education 0.16 0.001 0.07 – 0.39
  *  , Diabetes refers diabetes or no diabetes (1    diabetes; 0    no diabetes);   †  , education was measured as 
1    primary schooling or lower; 2    secondary schooling or higher;   ‡  , married    1; not presently married, 
i.e. divorced, single, widowed    0 
 Table 6 Means and 95% confi dence interval (CIs) of Menopause-specifi c Quality of Life (MENQOL) 
symptoms, associated with both diabetes and postmenopausal stage ( n    337) 
 Items 
 Diabetes  Control 
 p Value  Mean  95% CI  Mean  95% CI 
Feeling depressed, down or blue 2.53 2.26 – 2.80 1.88 1.55 – 2.22 0.008
Feeling anxious or nervous 2.27 2.02 – 2.52 1.76 1.46 – 2.05 0.023
Diffi culty sleeping 3.02 2.68 – 3.36 2.33 1.89 – 2.78 0.026
Feeling tired or worn out 3.99 3.68 – 4.29 3.07 2.67 – 3.48 0.001
Feeling a lack of energy 3.77 3.46 – 4.10 2.43 2.10 – 2.77 0.001
Dry skin 2.63 2.35 – 2.91 2.49 2.13 – 2.85 0.581
Frequent urination 2.52 2.23 – 2.80 2.00 1.67 – 2.33 0.039
Avoiding intimacy 1.64 1.42 – 1.85 1.48 1.28 – 1.68 0.411
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be sampled than those who attended less frequently, and there-
fore were presumed to have better quality of life. This might 
have introduced selection bias. This study is further limited 
by indirect validation of the sexual domain against marital 
status. This is based on the expectation that married women 
would be more bothered by the menopausal symptoms of this 
domain 22,34 . There may have been participant recall bias 
which would be a systematic error resulting from lack of com-
pleteness of memory of past events or experiences, which may 
have affected accuracy of self-reported information. 
 CONCLUSION 
 The MENQOL questionnaire appears to be reliable and valid 
instrument based on good internal consistency and signifi cant 
correlations with validated instruments. This fi nding confi rms 
the construct validity of MENQOL and it was found to be a 
valid measure to examine quality of life in postmenopausal 
women with diabetes. All four domains on the MENQOL did 
not predict the risk of diabetes. However, it should be noted 
that symptoms associated with both diabetes and the post-
menopausal phase had signifi cantly higher mean scores in 
diabetes subjects compared to control subjects. The psycho-
social domain was signifi cantly associated with depression, 
suggesting that scores on this domain of the MENQOL may 
be indicators of depression symptoms. 
 Confl ict of interest  The authors report no confl ict of 
interest. The authors alone are responsible for the content 
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